Australis Capital Valuation

Is AUSA.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AUSA.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AUSA.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AUSA.F's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AUSA.F?

Key metric: As AUSA.F is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for AUSA.F. This is calculated by dividing AUSA.F's market cap by their current book value.
What is AUSA.F's PB Ratio?
PB Ratio	n/a
Book	CA$26.21m
Market Cap	CA$6.36m

AUSA.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does AUSA.F's PB Ratio compare to its peers?

The above table shows the PB ratio for AUSA.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	0.7x
SHWZ Medicine Man Technologies	0.05x	n/a	US$4.5m
ARTL Artelo Biosciences	0.6x	10.2%	US$4.0m
INM InMed Pharmaceuticals	0.5x	n/a	US$3.9m
CMND Clearmind Medicine	1.6x	n/a	US$5.6m
AUSA.F Australis Capital	n/a	n/a	US$6.4m

Price-To-Book vs Peers: Insufficient data to calculate AUSA.F's Price-To-Book Ratio vs. peers for valuation analysis.

Price to Book Ratio vs Industry

How does AUSA.F's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

23 Companies	Price / Book	Estimated Growth	Market Cap

23 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: Insufficient data to calculate AUSA.F's Price-To-Book Ratio vs. industry for valuation analysis.

Price to Book Ratio vs Fair Ratio

What is AUSA.F's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AUSA.F PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	n/a
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate AUSA.F's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.